(Q33314977)

English

Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Escherichia coli

1 reference

based on heuristic

inferred from title

Graham L Randall

object named as

Graham L Randall

3

0 references

2

object named as

Robert L Atmar

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Lauren Becnel Boyd

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Richard J Hamill

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

David Steffen

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Lynn Zechiedrich

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

15 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

BMC Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2334-8-4

0 references

Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

The worldwide emergence of plasmid-mediated quinolone resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

The use of systemic fluoroquinolones

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Drug-resistant Escherichia coli, Rural Idaho

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Mechanisms of resistance to quinolones

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Fluoroquinolone prescribing in the United States: 1995 to 2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Multi-resistant Gram-negative bacilli: from epidemics to endemics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

COPD: management of acute exacerbations and chronic stable disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258293

21 June 2018

Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-4

21 January 2018

Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America).

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-4

21 January 2018

Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99).

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-4

21 January 2018

Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-4

21 January 2018

Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-4

21 January 2018

Antibiotic resistance of urinary pathogens in female general practice patients

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-4

21 January 2018

Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-4

21 January 2018

Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-4

21 January 2018

Fluoroquinolone Antimicrobial Agents in the Treatment of Prostatitis and Recurrent Urinary Tract Infections in Men

1 reference

https://pubmed.ncbi.nlm.nih.gov/18197977

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility surveillance among gram-negative bacilli at a cancer center

1 reference

https://pubmed.ncbi.nlm.nih.gov/18197977

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-8-4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33314977&oldid=1784289895"